Colmegna Inés, Maldonado-Cocco José A
LSU Medical Center, 1542 Tulane Ave., New Orleans, LA 70112, USA.
Curr Rheumatol Rep. 2005 Aug;7(4):288-96. doi: 10.1007/s11926-005-0039-2.
Polyarteritis nodosa (PAN), the prototype of systemic vasculitis, is a rare condition characterized by necrotizing inflammation of medium-sized or small arteries without glomerulonephritis or vasculitis in arterioles, capillaries, or venules. Signs and symptoms of this disease are primarily attributable to diffuse vascular inflammation and ischemia of affected organs. Virtually any organ with the exception of the lungs may be affected, with peripheral neuropathy and symptoms from osteoarticular, renal artery, and gastrointestinal tract involvement being the most frequent clinical manifestations. A clear distinction between limited versus systemic disease and idiopathic versus hepatitis B related PAN should be done because there are differences in the implicated pathogenetic mechanisms, their treatment, and prognosis. Currently, corticosteroids plus cyclophosphamide is the standard of care for idiopathic PAN, in particular for patients with adverse prognostic factors (more severe disease), in whom this combination prolonged survival. In contrast for hepatitis B related PAN treatment consists of schemes that include plasmapheresis and antiviral agents.
结节性多动脉炎(PAN)是系统性血管炎的原型,是一种罕见疾病,其特征为中、小动脉的坏死性炎症,不累及肾小球肾炎,也不累及小动脉、毛细血管或小静脉的血管炎。该疾病的体征和症状主要归因于受累器官的弥漫性血管炎症和缺血。除肺部外,几乎任何器官都可能受累,周围神经病变以及骨关节炎、肾动脉和胃肠道受累的症状是最常见的临床表现。应明确区分局限性疾病与系统性疾病以及特发性PAN与乙型肝炎相关的PAN,因为它们在涉及的发病机制、治疗方法和预后方面存在差异。目前,皮质类固醇加环磷酰胺是特发性PAN的标准治疗方案,特别是对于具有不良预后因素(病情更严重)的患者,这种联合治疗可延长生存期。相比之下,乙型肝炎相关PAN的治疗方案包括血浆置换和抗病毒药物。